Drug Metabolism and Bioanalysis

Aims and Scope:
Drug Metabolism and Bioanalysis is an interdisciplinary, peer-reviewed journal that publishes letters, original research papers, mini-reviews, and guest-edited issues in all important aspects of drug metabolism, pharmacokinetics, and bioanalysis.
The scope includes in vitro systems, including CYP-450; enzyme induction and inhibition; drug-drug interactions and enzyme kinetics; pharmacokinetics, toxicokinetics, species scaling and extrapolations; P-glycoprotein and transport carriers; target organ toxicity and interindividual variability; drug metabolism and disposition studies; extrahepatic metabolism; phase I and phase II metabolism; bioactivation; recent developments for the identification of drug metabolites, reactive intermediate, and glutathione conjugates.

Additionally, LC/MS and other key detection methods, including ligand binding assays, sample preparation, chromatography and separation sciences, and method development and validation, are included, with applications in drug and metabolite assays, pharmacokinetic/toxicokinetic assays, biomarker assays, immunogenicity assays, diagnostic assays. Topics covered in this interdisciplinary journal include:

  1. Analytical Method and Drug Metabolism
  2. Bioavailability and Biopharmacy
  3. Cytochrome 450 Drug Metabolism
  4. Cytotoxicity
  5. Drug Absorption and Disposition
  6. Drug Biotransformation
  7. Drug Delivery System
  8. Drug-Drug Interaction
  9. Drug Food Interaction
  10. Drug Metabolizing Enzymes
  11. Drug Toxicology
  12. Drug Transporters
  13. Drugs and CYP2D6
  14. Factors Affecting Drug Metabolism
  15. Hepatic Metabolism of Drugs
  16. P-Glycoprotein and Transport Carriers
  17. Pharmacokinetics and Pharmacodynamics
  18. Phase I and II Drug Metabolism
  19. Reactive Metabolites
  20. Therapeutic Drug Monitoring
  21. Xenobiotics
Drug Metabolism and Bioanalysis is an international, peer-reviewed journal on all aspects of drug metabolism and bioanalysis published half-yearly (print & online) by Bentham Science Publishers.
Read more...

Editor-in-Chief:

  • Zhiyang ZhaoResolian
    Malvern, PA
    United States of America

ISSN: 3117-3853 (Print)

eISSN: 3117-3861 (Online)

Special Issues With Active Call for Papers

Submission closes on: Oct 24, 2026
Advancements in Drug Discovery: Metabolic Pathways and Bioanalysis of Promising Bioactive Compounds.

The field of drug discovery has witnessed tremendous progress, with an increasing number of novel bioactive compounds showing potential in the treatment of complex diseases. However, understanding the metabolism of these compounds, along with their pharmacokinetics and bioanalysis, remains a critical step in the drug development process. The way in which bioactive compounds are metabolized can significantly influence their efficacy, toxicity, and overall therapeutic potential. Moreover, bioanalytical techniques are vital in tracking these compounds within... see more

Submission closes on: Oct 24, 2026
Recent Advances in Metal-Organic Frameworks (MOFs) and Coordination Compounds for Drug Delivery and Metabolic Applications.

This thematic issue will focus on the design, synthesis, and application of metal-organic frameworks (MOFs) and coordination compounds for targeted drug delivery, modulation of metabolic pathways, and pharmacokinetic optimization. The issue aims to present recent advancements in fundamental research, translational studies, and computational approaches, highlighting both innovative strategies and practical applications. Topics include MOF-based controlled drug release, enzyme modulation using coordination compounds, hybrid MOF-biopolymer systems, enantioselective metabolism studies, pharmacokinetic enhancements, and predictive computational modeling of... see more